Combining Escitalopram with Atarax (Hydroxyzine): Safety Considerations
Escitalopram and hydroxyzine can be combined, but this requires careful monitoring due to the additive QT prolongation risk from escitalopram, particularly in patients with additional cardiac risk factors. 1
Primary Concern: QT Prolongation
The main safety issue is additive QT interval prolongation. Escitalopram is among the highest-risk SSRIs for QT prolongation (along with citalopram), while hydroxyzine is also listed as a QT-prolonging antihistamine 1, 2, 1. When combining two QT-prolonging medications:
- Risk increases when QTc exceeds 500 ms or when a drug increases QTc by >60-70 ms 1
- Women, elderly patients, and those with structural heart disease face higher risk 1
Risk Stratification Before Combining
Obtain a baseline ECG if:
- Patient already takes a QT-prolonging drug (which applies here)
- Electrolyte disturbances present (hypokalemia, hypomagnesemia)
- Concurrent diuretic use
- Renal impairment
- Female sex, age >60 years, or structural heart disease 1
Check and correct before initiating:
- Electrolytes (potassium, magnesium)
- Renal function
- Review all other medications for QT-prolonging agents 1
Safer Alternatives to Consider
If anxiety treatment is needed alongside an SSRI, consider:
- Switching from escitalopram to sertraline or paroxetine (negligible QT risk among SSRIs) 1
- Using benzodiazepines instead of hydroxyzine for acute anxiety (though note: benzodiazepines may reduce serotonergic transmission) 3
The 2023 Canadian Cardiovascular Society guidelines explicitly state that among SSRIs, "risk appears highest with citalopram and escitalopram and negligible with paroxetine and sertraline" 1.
If Combination is Necessary
When clinical circumstances require both medications:
- Start hydroxyzine at low doses and monitor closely 4
- Obtain ECG after initiating combination and with any dose changes 1
- Monitor electrolytes regularly, especially if patient takes diuretics 1
- Discontinue if QTc >500 ms or increases >60 ms from baseline 1
- Educate patient about symptoms requiring immediate attention: palpitations, syncope, dizziness 1
Additional Drug Interaction Considerations
Hydroxyzine potentiates CNS depression when combined with other CNS depressants 4. While escitalopram can cause sedation, this interaction is generally manageable with:
- Warning patients about additive drowsiness
- Avoiding driving/operating machinery until effects are known
- Avoiding alcohol 5, 4
Escitalopram has minimal CYP450 interactions compared to other SSRIs, which reduces concern for pharmacokinetic interactions with hydroxyzine 6.
Clinical Evidence
Limited research suggests the combination may be used in specific populations. One study in adolescents with avoidant/restrictive food intake disorder found that SSRI+hydroxyzine combinations were effective, though hydroxyzine was reserved for patients with particularly high anxiety 7. However, this does not address the cardiac safety concerns in broader populations.
Common Pitfall
Do not assume all SSRIs carry equal cardiac risk. The evidence clearly distinguishes escitalopram/citalopram as higher-risk agents. If the clinical situation allows, switching to sertraline or paroxetine eliminates the primary concern with this combination 1.